1/2

FIEO Registered Export Ready

Levocetirizine, Montelukast &Ambroxol Hydrochloride(Sustained Release) Tablets

Name: Levocetirizine, Montelukast &Ambroxol Hydrochloride(Sustained Release) Tablets
Brand: indiglobal exports
SKU: 8520353
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Levocetirizine, Montelukast & Ambroxol Hydrochloride (Sustained Release) Tablets is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of respiratory conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Respiratory Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Levocetirizine, Montelukast & Ambroxol Hydrochloride (Sustained Release) Tablets is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Category	Respiratory
Drug Form	Tablet
Release Profile	Sustained Release
Packaging Type	Blister / Strip Packs
Compliance Standards	IP/USP, WHO-GMP
Intended Use	Treatment of respiratory allergies, asthma, bronchitis
Storage Conditions	Store in a cool, dry place away from direct sunlight
Shelf Life	According to regulatory requirements; typically 2 years
Dosage Form Appearance	Tablet suitable for oral administration
Manufacturer	IndiGlobal Exports

Use cases

Category	Pharmaceuticals > Respiratory Medicines > Combination Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Levocetirizine, Montelukast &Ambroxol Hydrochloride(Sustained Release) Tablets. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the advantage of the sustained release formulation in these tablets?

A: The sustained release formulation ensures a controlled and prolonged release of Levocetirizine, Montelukast, and Ambroxol Hydrochloride, maintaining consistent therapeutic levels over time and reducing the frequency of dosing, thereby improving patient compliance.

Q: Is this product suitable for export to international regulated markets?

A: Yes, the tablets are manufactured under WHO-GMP standards and comply with IP/USP pharmacopoeial quality benchmarks, making them suitable for export to regulated and semi-regulated international pharmaceutical markets.

Q: How does this combination benefit respiratory patients compared to single-agent therapy?

A: This combination targets multiple pathways in respiratory conditions: Levocetirizine acts as an antihistamine to reduce allergic symptoms, Montelukast blocks leukotriene receptors to prevent bronchoconstriction, and Ambroxol Hydrochloride acts as a mucolytic to thin mucus, collectively offering comprehensive relief.

Q: What type of packaging is used to ensure the product's stability during export?

A: The product is supplied in export-grade blister or strip packs that provide protection against moisture and contamination, ensuring the tablets' stability and integrity during transport and storage.

Q: Can hospitals and retail pharmacies source this product for patient treatment?

A: Yes, the formulation is designed to meet the needs of hospitals, retail pharmacies, and institutional suppliers requiring quality-assured respiratory therapy tablets.

Question not answered? Ask sellers directly — typical response within 4 hours.